Nu Skin Reports Mixed Q1 Results, Early Signs of Field Stabilization Emerge

Nu Skin Enterprises Inc. (NYSE: NUS) reported first-quarter 2026 financial results that came in near the low end of guidance, with revenue of $320.6 million and adjusted earnings per share of $0.14, compared to Stonegate Capital Partners’ estimates of $329.7 million and $0.15, respectively. The company maintained its full-year guidance, signaling confidence in a second-half recovery driven by the continued rollout of its Prysm iO platform and expansion into emerging markets.

Adjusted net income for the quarter was $6.8 million, while core Nu Skin gross margin improved 20 basis points year-over-year to 76.9%. However, adjusted operating margin contracted to 3.6% from 6.4% in the prior year, reflecting ongoing investments behind Prysm iO and emerging markets. Despite the margin pressure, management emphasized cost discipline as a key factor keeping adjusted EPS within the guided range.

The most significant development highlighted by management was early field stabilization. Although headline key performance indicators remained under pressure—with sales leaders, paid affiliates, and customers declining 13%, 8%, and 14% year-over-year, respectively—the company reported that brand affiliate confidence improved and new sales leaders grew year-over-year exiting the quarter. This suggests that the field organization is beginning to stabilize as Prysm iO training and leader engagement scale.

Prysm iO, Nu Skin’s personalized beauty and wellness platform, remains the core commercialization catalyst. The company disclosed nearly 2 million scans across over 30,000 devices, indicating early adoption. Additionally, subscription volume grew 5% year-over-year, suggesting that the platform is beginning to enhance customer engagement and recurring revenue quality. The company plans to launch Prysm iO in India by year-end, which could provide a further growth catalyst.

Nu Skin maintained its full-year 2026 revenue guidance of $1.35 billion to $1.50 billion and adjusted EPS guidance of $0.80 to $1.20. This implies a significant improvement in the second half of the year, supported by broader Prysm iO adoption, the India launch, and continued cost discipline. Stonegate Capital Partners, which updated its coverage on the stock, noted that the maintained guidance reflects management’s confidence in the trajectory of the business.

Investors can view the full announcement, including downloadable images and bios, here. Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies.

This news story relied on content distributed by Reportable. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is Nu Skin Reports Mixed Q1 Results, Early Signs of Field Stabilization Emerge.

The post Nu Skin Reports Mixed Q1 Results, Early Signs of Field Stabilization Emerge appeared first on citybuzz.